We studied the intrahepatic disposition characteristics of galactosylated polyethylenimine (Gal-PEI) W plasmid DNA (pDNA) complexes using rat liver perfusion experiment. After intraportal administration, transfection activity in liver of Gal-PEI complexes was approximately 26-fold higher than that of native PEI complexes. To evaluate the relationship between hepatic gene expression and disposition proˆles, hepatic disposition of Gal-PEI complexes were pharmacokinetically analyzed by use of perfused rat liver, which enables uptake characteristics intrinsic to the liver to be elucidated. Moment analysis revealed that both complexes exhibited very high single-pass extraction. To characterize each kinetic process in hepatic uptake of Gal-PEI complexes, their out‰ow proˆles were analyzed based on a two-compartment dispersion model. Consequently, the tissue binding a‹nity of Gal-PEI complexes was 3.0-fold larger than that of native PEI complexes, suggesting the increasing of hepatic binding a‹nity much enhanced the hepatic gene transfection e‹ciency. In contrast, galactosylation of PEI did not aŠected internalization (and W or sequestration) rate.
Introduction
Gene delivery to hepatocytes is of great therapeutic potential, since the cells are responsible for the synthesis of a wide variety of proteins which play important biological roles inside or outside the liver. 1) In a series of experiments, we have focused on receptor-mediated in vivo gene delivery to hepatocytes and developed several types of poly-L-lysine (PLL) 2, 3) and cationic liposomes 4, 5) as gene carriers. Of the non-viral macromolecular vectors reported so far, polyethylenimine (PEI) is one of the most eŠective polymers in transferring plasmid DNA (pDNA) into cells in vitro 6) and in vivo. 6, 7) PEI is believed to enter the cell via an endocytotic route, and to possess a buŠering capacity and an ability to swell when protonated. 6, 8) Since the lysosomal degradation is a critical hurdle for transgene expression by non-viral delivery of pDNA, PEI has relatively high transfection e‹ciency among polymeric non-viral vectors such as PLL. Recently, we reported that the galactosylated PEI (Gal-PEI) W pDNA complexes could transfect the reporter gene to the liver selectively after intraportal administration. 9) However, the level of gene expression due to Gal-PEI W pDNA complex was not still so high as to be expected by in vitro results. There must be several barriers associated intrinsically with in vivo situations, such as convective blood ‰ow in the liver, passage through the sinusoids, and interaction with the tissues, serum 10, 11) and erythrocytes 12) etc. For rational design of eŠective gene carriers, detailed information on these barrier properties is needed. In vitro experiments have been carried out to quantitative-ly or visually characterize cellular uptake or sub-cellular transport of exogenous genes complexed with their carrier systems. Although in vitro data give useful information about the optimization of the intracellular fate of delivery systems, it appears to be more critical to control their disposition at the whole body level. Therefore, we have extensively been studying the pharmacokinetics of naked pDNA 13) or that complexed with carriers systems, 4, 14) as well as carrying out in vitro studies. 15, 16) However, the in vivo distribution study of radiolabeled pDNA is not necessarily enough to delineate the characteristics of various barrier processes. Alternatively, a single-pass liver perfusion experiment appears to be suitable for this purpose. We have already used a rat liver perfusion system to determine the hepatic disposition characteristics of low-molecular-weight drugs, macromolecules, and drug carrier systems. [17] [18] [19] [20] When [
32 P]-labeled naked pDNA is injected into the isolated perfused liver, it is extensively taken up by the liver and the uptake obeys a saturable kinetics. 21) Moreover, the total recovery of naked pDNA in the liver was reduced substantially by pre-administration of polyinosinic acid, dextran sulfate, succinylated bovine serum albumin, but not by polycytidylic acid, suggesting that pCAT is taken up by the liver via scavenger receptors for polyanions on the NPC. Thus, a liver perfusion system allowed us to depict the uptake characteristics of various molecules and complexes with the structure of the liver being intact.
In the present study, we investigated the local disposition of Gal-PEI W pDNA complexes using a single-pass rat liver perfusion system. The venous out‰ow proˆle of the complexes following a bolus input into the isolated perfused liver was analyzed by a two-compartment dispersion model to quantitatively evaluate the diŠerence in each kinetic process between native PEI and galactosylated PEI complexes. We selected Gal-PEI having a molecular weight of 10000 (converted into native PEI), considering both transfection activity and cytotoxicity in vitro.
9)

Materials and Methods
Materials: Poly(ethyleneimine) 30z aqueous solution (MW:10000) was obtained from Polysciences, Inc. (Warrington, USA). [a-
32 P]-dCTP (3000Ci W mmol) was obtained from Amersham (Tokyo, Japan). Clear-Sol I was obtained from Nacalai Tesque (Kyoto, Japan), and Soluene 350 was purchased from Packard (Groningen, Netherlands). All other chemicals were of the highest purity available.
Construction and preparation of pDNA: pCMVLuc was constructed by subcloning the Hind III W Xba Î re‰y luciferase cDNA fragment from pGL3-control vector (Promega, Madison, WI, USA) into the polylinker of pcDNA3 vector (Invitrogen, Carlsbad, CA, USA). pDNA was ampliˆed in the E coli strain DH5a, isolated, and puriˆed using a QIAGEN Endofree Plasmid Giga Kit (QIAGEN GmbH, Hilden, Germany). Purity was conˆrmed by 1z agarose gel electrophoresis followed by ethidium bromide staining and the DNA concentration was measured by UV absorption at 260 nm. The pDNA was labeled with [a-
32 P]-dCTP by nick translation.
22)
Synthesis of Gal-PEI: Galactosylation of PEI was carried out using 2-imino-2-methoxyethyl-1-thiogalactoside according to the method previously reported. 9) The number of galactose units on PEI was controlled by the molar ratio of the starting materials. The Gal-PEI obtained was puriˆed by dialysis and freeze-dried. The number of galactose units was determined by measurement of the galactose content by anthrone-surfuric acid method. 23) Gal9-PEI10000 (PEI10000 with 9 galactose units) were obtained. Since the method used for galactosylation hardly alters the electric charge of modiˆed molecules, 24) theˆnal amine concentration in the conjugates was calculated on the assumption that the eŠective number of amine groups in PEI is not altered by galactosylation.
Preparation of PEI W pDNA Complexes: Nine hundreds microliters of 200 mg W mL pDNA in sterile 5z dextrose was mixed with the equal volume of PEI varying in their concentration and incubated for 30 min at room temperature. The mixing ratio of PEI and pDNA was expressed as a N W P ratio, which is a molar ratio of nitrogen atoms of PEI to the phosphate groups of pDNA.
25) The N W P ratio is unity when 0.13 mg native PEI or 0.16 mg Gal-PEI is mixed with 1 mg pDNA. To prevent aggregation of the complexes, the pH of native and Gal-PEI were adjusted to 7.4 by HCl before mixing with pDNA. The particle size and zeta potential of PEI W pDNA complexes were measured, using a dynamic light scattering spectrophotometer (LS-900, Otsuka Electronics, Osaka, Japan) and a laser electrophoresis zeta-potential analyzer (LEZA-500T, Otsuka Electronics), respectively.
In vivo Experiment: ICR mice (female, 20-23 g) were purchased from the Shizuoka Agricultural Co-operative Association for Laboratory Animals (Shizuoka, Japan) and maintained on standard food and water under conventional housing conditions. All animal experiments were carried out in accordance with the Guidelines for Animal Experiments of Kyoto University. Mice were anesthetized with peritoneal injection of pentobarbital sodium (50 mg W kg). An incision was made in the abdomen, and the portal vein was exposed. Thirty micrograms of pDNA complexed with PEI were injected into the portal vein, and the abdomen was closed by clips. At 6 h after injection, the liver and other organs were excised. Each organ was homogenized with a lysis buŠer (0.1 M Tris W HCl containing 0.05z Triton X-100 and 2 mM EDTA (pH 7.8)). After three cycles of freezing and thawing, the homogenates were centrifuged at 10,000 g for 10 min at 49 C. Twenty microliters of each supernatant was mixed with 100 mL of luciferase assay solution (Picagene, Toyo Ink, Tokyo, Japan) and light produced was immediately measured using a luminometer (Lumat LB 9507, EG&G Berthold, Bad Wild-bad, Germany). The protein contents of each supernatant were also determined.
Liver Perfusion Experiment: Male Wistar rats (170-210 g) were purchased from the Shizuoka Agricultural Cooperative Association for Laboratory Animals (Shizuoka, Japan). All animal experiments were carried out in accordance with the Principles of Laboratory Animal Care as adopted and promulgated by the US National Institutes of Health and the Guideline for Animal Experiments of Kyoto University.
In situ liver perfusion studies were carried out as reported previously. 17) Rats were anesthetized by intraperitoneal injection of sodium pentobarbital (60 mg W kg). The portal vein was catheterized with a polyether nylon catheter (SURFLO } I.V. Catheter, 16 G×2!, Terumo, Tokyo, Japan) and immediately perfused with Krebs-Ringer bicarbonate buŠer supplemented with 10 mM glucose (oxygenated with 95z O2-5z CO2, adjusted to pH 7.4 at 379 C). The inferior vena cava was catheterized through the right atrium with a polyethylene tube (PE-160) and also ligated immediately above the renal vein. The perfusate was circulated using a peristaltic pump (SJ-1211, ATTO Co., Tokyo, Japan) at a ‰ow rate of 13 mL W min. After a stabilization period of 25 min, PEI W [ 32 P] pDNA complexes (30 mg DNAW 300 mL) were administered to the portal vein using a six-position rotary valve injector (Type 50 Te‰on rotary valves, Rheodyne Inc., Cotati, CA, USA). Samples of venous out‰ow were collected into the preweighed tubes and the volumes were estimated from the weight gain. The sampling time was calculated from each sample volume, assuming a constant ‰ow rate. The lag-time of the catheter between the injector and the liver was estimated from the catheter volume and ‰ow rate. After completion of the perfusion experiment, the entire liver was excised, weighed and homogenized. The radioactivity of the eOEuent perfusate was measured in a scintillation counter (LSA-500, Beckman, Tokyo, Japan) after addition of 5 mL Clear-Sol I. The radioactivity of liver homogenates was measured after incubation with Soluene-350 overnight at 459 C and mixing with 0.2 mL isopropanol, 0.2 mL 30z hydrogen peroxide, 0.1 mL 5 N HCl, and 5 mL Clear-Sol I in that order.
Pharmacokinetic Analysis: The out‰ow patterns were analyzed by statistical moment analysis for local injection as reported previously. 26) Brie‰y, the area under the curve (AUC) and mean residence time (MRT) were calculated as follows:
where t is the time and C is the concentration of [ 32 P] pDNA complexed with PEI. The moments can be calculated by numerical integration using a linear trapezoidal formula and extrapolation to inˆnite time based on a monoexponential equation. 27) The t values were corrected for the lag-time of the catheter. The recovery ratio (F) and extraction ratio (E) were derived from F＝ AUC･Q (‰ow rate) and E＝1-F, respectively.
The out‰ow patterns were also analyzed based on a two-compartment dispersion model, where sinusoidal and binding compartments were considered. The mass balance equations involving the axial dispersion in the sinusoidal space are given as follows:
where CS(t, z) and CB(t, z) are the concentration of drug in the sinusoidal space and binding compartment, respectively; D is the dispersion coe‹cient; e is the volume ratio of the binding compartment to the sinusoidal space in the liver; k12 and k21 are the forward and backward partition rate constants between the sinusoidal space and binding compartment; kint is thê rst-order internalization (and W or sequestration) rate constant from the binding compartment to the intracellular space; v is the linear ‰ow velocity of the perfusate; t is time; and z is the axial coordinate in the liver. The initial and boundary conditions are given as:
where M is the amount of drug injected into the liver, Q is the ‰ow rate of the perfusate. fI(t) has the dimension of the reciprocal of time. Taking the Laplace transform with respect to t, rearranging, substituting the length of the sinusoidal space L with z and introducing the crosssectional area of the sinusoidal space A, the following image equation is obtained: where CS(s) and fI(s) denote the Laplace transform of concentration in the venous out‰ow and input function fI(t), respectively. DC is the corrected dispersion coe‹cient (DC＝D･A 2 ), VS is the sinusoidal volume (＝L･A) and the ‰ow rate Q is equal to A･v.
Each parameter (DC, k12, k21, kint and VS) was calculated by curveˆtting of the Laplace-transformed equation to the experimental venous out‰ow pattern using a nonlinear least squares program with a fast inverse Laplace transform algorithm MULTI (FILT).
29) The damping Gauss Newton method with no constraint was used for curveˆtting the MULTI algorithm. Here, fI(t) was assumed to be a delta function, since the PEI W pDNA complexes were rapidly injected using a sixrotary valve injector.
Statistical Analysis: Statistical comparisons were performed by Student's t test for two groups, one-way ANOVA for multiple groups and ScheŠe's post hoc test after ANOVA.
Results
Physicochemical characteristics of PEI W pDNA complexes: Table 1 shows particle size and zeta potential of native and galactosylated PEI W pDNA complexes. The particle sizes of PEI complexes were approximately 100 nm except for Gal-PEI complexes at N W P ratio of 6. Regardless of N W P ratio, the zeta potentials of native and galactosylated PEI complexes were very high values and the values were approximately 55 mV and 40 mV, respectively.
Transfection activity of PEI W pDNA complexes after intraportal administration: To check transfection activity of native and Gal-PEI complexes used in this study, luciferase activity in liver was measured 6h after intraportal administration. The transfection activity for Gal-PEI W pDNA complexes at N W P ratio of 10 was 3624 ±1486 RLU W mg protein (n＝3) and approximately 12-fold higher than 302±232 RLU W mg protein (n＝3) at N W P ratio of 6. At NW P ratio of 10, the transfection activity for Gal-PEI W pDNA complexes was approximately 26-fold higher than 137±19.9 RLU W mg protein (n＝3) for native PEI complexes. Subsequently, hepatic disposition of Gal-PEI W pDNA complexes at N W P ratio of 10, which exhibited high transfection activity, were pharmacokinetically analyzed by use of perfused rat liver.
Uptake of PEI W pDNA complexes by perfused rat liver: Figure 1 shows typical venous out‰ow proˆles of native and galactosylated PEI W [ 32 P] pDNA complexes at N W P ratio of 10 following bolus injection into perfused rat liver. The out‰ow proˆle of Gal-PEI W pDNA complexes ( Fig. 1(b) ) was similar to that of native PEI W pDNA complexes ( Fig. 1(a) ). Moment analysis was performed to quantitatively describe the out‰ow pattern. The AUC value of Gal-PEI complexes was comparable to that of native PEI complexes, whilst the MRT value of Gal-PEI complexes was signiˆcantly smaller ( Table 2) .
Analysis based on a two-compartment dispersion model: To characterize each kinetic process in hepatic uptake of Gal-PEI W pDNA complexes, their out‰ow proˆles were analyzed based on a two-compartment dispersion model. As shown in Fig. 1 , the simulation curves using the model were in good agreement with the observed data. Table 3 summarizes the parameters obtained by curve-ˆtting to the observed data. Assuming that PEI W pDNA complexes are bound to the tissue surface and internalized (and W or sequestrated) into the liver, the k 12 W k 21 value represents a binding a‹nity to the liver tissue, while the kint value represents an e‹ciency of internalization (and W or sequestration) of native PEI W pDNA complexes bound to the tissue. The k12 W k21 value of Gal-PEI W pDNA complexes was 3.0-fold larger than that of native PEI W pDNA complexes, while the k int value of the former was comparable to that of the latter.
Discussion
Gene carriers with speciˆc ligands for the corresponding receptors on the cell surface are useful for targeted gene delivery. Among various ligands examined so far, galactose has been shown to be a promising targeting ligand to hepatocytes (liver parenchyma cells) because the cells possess a large number of the asialoglycoprotein receptors that recognize the galactose units on the oligosaccharide chains of glycoproteins. 30) Several investigations, 31, 32) including our report, 9) have already studied glycosylated PEI for the cell-selective gene transfection using cell culture system because of high transfection potential of PEI. We have also examined their in vivo transfection activity, indicating that liver parenchymal cell-selective transgene expression following the intraportal administration of Gal-PEI complexes was mediated by asialoglycoprotein receptor. However, these studies mainly focused on transfection e‹ciency. Little attention has been paid to the disposition properties of PEI complexes.
We have been emphasizing the importance of pharmacokinetic considerations towards various delivery systems. 13, 14, [17] [18] [19] [20] [21] [33] [34] [35] Pharmacokinetic analysis based on the clearance concept revealed that physicochemical properties such as the molecular weight and electrical charge are important in determining the in vivo disposition proˆles of drug-macromolecule conjugates, 33) chemically modiˆed proteins, 34) and pDNA W PLL complexes. 35) Theseˆndings indicated that the amount of drugs delivered to the target is determined by not only the ligands grafted to carriers but also the overall physicochemical properties of the macromolecular compounds. Thereby, even PEI-based gene delivery systems would not be exceptional for their pharmacokinetic evaluations. To this end, we performed liver perfusion studies that allow us to evaluate local disposition behavior of the carrier systems.
Atˆrst, we pharmacokinetically analyzed the venous out‰ow pattern using statistical moment analysis ( Table 2) . Native PEI complexes exhibited extremely high extraction ratio, suggesting PEI has great potential for delivery of pDNA to the liver. Moreover, Gal-PEI produced signiˆcantly shorter MRT than native PEI, while keeping an extraction ratio high. To discuss how much each kinetic process contributed to the diŠerence in MRT, we performed the two-compartment dispersion model analysis. The model analysis clariˆed that both native and galactosylated PEI complexes indicated a high tissue association rate (k12) at the same degree. In contrast, the dissociation rate (k21) of Gal-PEI complexes was signiˆcantly smaller than that of native PEI complexes (Table 3) , resulting in higher tissue binding a‹nity (k 12 W k 21 ). Taking together with that native PEI complex itself showed a high tissue binding a‹nity due to its strong positive charge ( Table 1) , augmentation of tissue binding by galactosylation appears to be very noticeable. Increased tissue binding a‹nity by galactosylation would be one of the reasons why transgene expression in the liver was increased. This result corresponded well to our previousˆnding that in vitro uptake by HepG2 cells was increased by galactosylation. 9) On the other hand, galactosylation of PEI did not aŠect an internalization (and W or sequestration) rate. Taking smaller dissociation rate of Gal-PEI complexes into consideration, internalization amount at steady state could be relatively increased. This diŠerence in internalization process would be also one of the reasons why transgene expression in the liver was increased by galactosylation of PEI. Additionally, the zeta potential of Gal-PEI complexes at N W P ratio of 10 was smaller than that of native PEI complexes (Table 1) , proposing less toxicity and higher pDNA release ability of Gal-PEI. As consequence, these possibilities might contribute to higher transfection activity of Gal-PEI complexes.
In two-compartment dispersion model analysis,ˆve intrinsic parameters were estimated by curve-ˆtting to a single out‰ow pattern. However, reliability of estimated parameters would be guaranteed by their small standard deviation. In addition, the volume of sinusoidal space (VS) was almost constant in the experiments (Table 3) . When the out‰ow proˆle of 111 In-BSA that little interacts with the tissue was analyzed based on a two-compartment dispersion model where the ke equals to be zero, the VS value was estimated to be 0.21±0.05 mL W g tissue. 39 ) Thus, such consistency in the physiological parameter suggests the validity of the present model. The reasons we applied two-compartment dispersion model are as follows; (i) the dispersion model enables to consider early-phase proˆle of out‰ow pattern, which largely contributed to high extraction ( Fig. 1) , (ii) out‰ow pattern after peak concentration exhibited typical two-compartment proˆle (Fig. 1) , (iii) the constant infusion mode, which enables diŠerential analysis of binding and internalization processes at steady state, 20) was not suitable in this study because [
32 P] labeled pDNA would be degraded and degraded [ 32 P] pDNA fragments would be contaminated in perfusate at steady state. The particle size of complexes is an important factor for the e‹cient hepatic gene delivery systems, considering that the complexes must penetrate the capillary walls. Liver sinusoidal endothelium possesses pores and intercellular junctions of about 200 nm or less. [36] [37] [38] In the present study, therefore, we focused on the complexes at a N W P ratio of 10, which have a smaller particle size ( Table 1) . The PEI complexes appear to be small enough to penetrate the fenestrated endothelium. This would be largely related to the high extraction ratio of both native and galactosylated PEI complexes ( Table 2) . At a N W P ratio of 6, however, the particle size of Gal-PEI complexes was very large ( Table 1) . When we measured transfection activity in the liver at 6h post intraportal administration of Gal-PEI complexes in mice (30 mg of pDNA per mouse), transgene expression of Gal-PEI complexes at N W P ratio of 6 (302±232 RLU W mg protein (n＝3)) was signiˆcantly smaller than that at N W P ratio of 10 (3624±1486 RLU W mg (n＝3)). Considering that the zeta potential of these complex was almost the same (Table 1) , the size of Gal-PEI W pDNA complexes might mainly aŠect the in vivo transgene expression of Gal-PEI complexes.
In conclusion, we delineated the hepatic disposition characteristics of native and galactosylated PEI complexed with pDNA using perfused rat liver. The two-compartment dispersion model analysis revealed that galactosylation of PEI increased a tissue binding, supporting the enhancement of hepatic transfection e‹ciency in our previous report. 9) 
